Vanda Pharmaceuticals Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Vanda Pharmaceuticals Inc. Return On Assets for the quarter ending September 30, 2024 was -2.52 %, a 237% decline year-over-year.
  • Vanda Pharmaceuticals Inc. annual Return On Assets for 2023 was 0.39 %, a 62% decline from 2022.
  • Vanda Pharmaceuticals Inc. annual Return On Assets for 2022 was 1.02 %, a 82.5% decline from 2021.
  • Vanda Pharmaceuticals Inc. annual Return On Assets for 2021 was 5.8 %, a 27.2% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -2.52 -4.36 -237% Jul 1, 2024 Sep 30, 2024
Q2 2024 -1.68 -4.03 -172% Apr 1, 2024 Jun 30, 2024
Q1 2024 -0.76 -3.3 -130% Jan 1, 2024 Mar 31, 2024
Q4 2023 0.39 -0.63 -62% Oct 1, 2023 Dec 31, 2023
Q3 2023 1.84 +0.77 +72% Jul 1, 2023 Sep 30, 2023
Q2 2023 2.34 +0.5 +27.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 2.54 -0.54 -17.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 1.02 -4.79 -82.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 1.07 -5.09 -82.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 1.84 -4.16 -69.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 3.08 -2.92 -48.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 5.8 +1.24 +27.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 6.16 +2.28 +58.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 6.01 -17.3 -74.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 6 -19.7 -76.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 4.57 -22.9 -83.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 3.88 -27.9 -87.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 23.3 +15 +180% Apr 1, 2020 Jun 30, 2020
Q1 2020 25.7 +19 +287% Jan 1, 2020 Mar 31, 2020
Q4 2019 27.5 +19.5 +245% Oct 1, 2019 Dec 31, 2019
Q3 2019 31.8 +27.2 +595% Jul 1, 2019 Sep 30, 2019
Q2 2019 8.32 +7.82 +1564% Apr 1, 2019 Jun 30, 2019
Q1 2019 6.63 +8.7 Jan 1, 2019 Mar 31, 2019
Q4 2018 7.98 +15.5 Oct 1, 2018 Dec 31, 2018
Q3 2018 4.57 +11.5 Jul 1, 2018 Sep 30, 2018
Q2 2018 0.5 +5.4 Apr 1, 2018 Jun 30, 2018
Q1 2018 -2.07 +4.37 +67.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -7.53 +1.17 +13.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -6.9 +8.62 +55.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -4.9 +14.7 +75% Apr 1, 2017 Jun 30, 2017
Q1 2017 -6.44 +13 +66.9% Jan 1, 2017 Mar 31, 2017
Q4 2016 -8.7 +9.6 +52.4% Oct 1, 2016 Dec 31, 2016
Q3 2016 -15.5 -37 -172% Jul 1, 2016 Sep 30, 2016
Q2 2016 -19.6 -50.2 -164% Apr 1, 2016 Jun 30, 2016
Q1 2016 -19.4 -46 -173% Jan 1, 2016 Mar 31, 2016
Q4 2015 -18.3 -35.9 -204% Oct 1, 2015 Dec 31, 2015
Q3 2015 21.5 +74.9 Jul 1, 2015 Sep 30, 2015
Q2 2015 30.6 +79.1 Apr 1, 2015 Jun 30, 2015
Q1 2015 26.5 +58.6 Jan 1, 2015 Mar 31, 2015
Q4 2014 17.6 +33.2 Oct 1, 2014 Dec 31, 2014
Q3 2014 -53.3 -38.6 -261% Jul 1, 2014 Sep 30, 2014
Q2 2014 -48.5 -33.6 -226% Apr 1, 2014 Jun 30, 2014
Q1 2014 -32.1 -15.2 -89.4% Jan 1, 2014 Mar 31, 2014
Q4 2013 -15.6 +2.3 +12.9% Oct 1, 2013 Dec 31, 2013
Q3 2013 -14.8 +1.33 +8.26% Jul 1, 2013 Sep 30, 2013
Q2 2013 -14.9 -1.06 -7.68% Apr 1, 2013 Jun 30, 2013
Q1 2013 -17 -7.47 -78.7% Jan 1, 2013 Mar 31, 2013
Q4 2012 -17.9 Oct 1, 2012 Dec 31, 2012
Q3 2012 -16.1 Jul 1, 2012 Sep 30, 2012
Q2 2012 -13.8 Apr 1, 2012 Jun 30, 2012
Q1 2012 -9.49 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.